𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Role of dopamine D-1 and D-2 receptor subtypes in mediating dopamine agonist effects on food consumption in rats

✍ Scribed by M. T. Martin-Iverson; C. T. Dourish


Publisher
Springer
Year
1988
Tongue
English
Weight
556 KB
Volume
96
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.

✦ Synopsis


The effects of selective D-2 and D-1 dopamine (DA) receptor agonists on food consumption were investigated in free-feeding rats. A selective D-2 receptor agonist, (+)-4-propyl-9-hydroxynaphthoxazine (PHNO), increased the consumption of standard food pellets in the dose range of 7.5-120 micrograms/kg, while SKF 38393 (5.0 mg/kg), a selective D-1 receptor agonist, decreased food pellet intake. The increase in food pellet intake produced by PHNO was blocked by haloperidol (an antagonist relatively selective for the D-2 receptor at the dose used, 0.05 mg/kg) and SCH 23390 (20 micrograms/kg, a D-1 receptor selective antagonist). Increasing "arousal" by disturbance associated with repeated food weighing also increased food pellet consumption, but did not diminish PHNO-elicited feeding. However, the same range of doses of PHNO (7.5-120 micrograms/kg) which increased food pellet intake decreased consumption of a liquid diet, and had no overall effect on a highly palatable liquid diet. The increase in consumption of solid food induced by PHNO appears to be secondary to enhancement of chewing behaviors. In contrast, the decrease in food intake induced by SKF 39393 may be due to a direct action of the drug on neural feeding mechanisms.


πŸ“œ SIMILAR VOLUMES


Biphasic effects of dopamine D-2 recepto
✍ Jaime M. Monti; Marjorie Hawkins; HΓ©ctor Jantos; Luisa D'Angelo; MΓ³nica FernΓ‘nde πŸ“‚ Article πŸ“… 1988 πŸ› Springer 🌐 English βš– 670 KB

The effects of the dopamine (DA) receptor agonists apomorphine, bromocriptine and pergolide were compared with those produced by a DA receptor antagonist, haloperidol, in rats implanted with electrodes for chronic sleep recordings. Apomorphine (0.025-2.0 mg/kg) and bromocriptine (0.25-6.0 mg/kg) ind

Antiparkinsonian effects of the novel D3
✍ Michael P. Hill; Paula Ravenscroft; Steven G. McGuire; Jonathan M. Brotchie; Ala πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 95 KB

L-dopa remains the most common treatment for Parkinson's disease. However, there is considerable interest in D3/D2 receptor agonists such as the novel agent S32504, since they exert antiparkinsonian properties in the absence of dyskinesia. An important question concerns the roles of D2 vs. D3 recept

Endurance training effects on striatal D
✍ P. G. MacRae; W. W. Spirduso; T. J. Walters; R. P. Farrar; R. E. Wilcox πŸ“‚ Article πŸ“… 1987 πŸ› Springer 🌐 English βš– 522 KB

Endurance training is associated with higher binding of 3H-spiperone to striatal D2 dopamine receptors of rats sacrificed 48 h following the last exercise bout (Gilliam et al. 1984). In the present study we investigated the effects of endurance training in presenescent older rats on the relationship